Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

FTSE 100 movers: Carnival buoyed by Q4 results, drugmakers higher

Thu, 19th Dec 2013 14:47

Cruise operator Carnival surged into the top spot on the FTSE 100 risers list on Thursday after reporting a smaller-than-expected decline in net revenue yields in the fourth quarter. Net revenue yields in constant dollars fell by 2.1 per cent year-on-year, better than the company's guidance given in September of a 3-4 per cent fall.AstraZeneca was higher after spending up to $4.1bn to buy out Bristol-Myers Squibb's stake in their diabetes joint venture, giving the Anglo-Swedish company full ownership of intellectual property and global rights for a large portfolio of products.Fellow pharma group GlaxoSmithKline (GSK) also advanced after US regulators approved Anoro Ellipta, its treatment for chronic obstructive pulmonary disease. Upside however was limited on the news that Denmark has approved the sale of a generic rival to GSK's biggest product, Advair.Precious metal miners Fresnillo and Randgold Resources were among the few fallers on the FTSE 100, with the stocks tracking heavy falls in gold and silver prices in afternoon trade.Glencore Xstrata was also lower. The company announced this morning that it has bought up a further 14.5% stake in Congolese copper and cobalt producer Mutanda Mining for $430m cash, taking its controlling stake to 69%.G4S was in the red after the government referred the security group to the Serious Fraud Office following a review of outsourcing contracts due to suspected over-charging.FTSE 100 - RisersCarnival (CCL) 2,318.00p +5.75%Petrofac Ltd. (PFC) 1,131.00p +3.86%William Hill (WMH) 387.70p +3.22%Standard Life (SL.) 350.10p +2.88%British Land Co (BLND) 615.50p +2.75%Hargreaves Lansdown (HL.) 1,305.00p +2.68%Associated British Foods (ABF) 2,391.00p +2.66%Land Securities Group (LAND) 951.00p +2.48%Smith & Nephew (SN.) 855.00p +2.27%Sage Group (SGE) 394.00p +2.26%FTSE 100 - FallersFresnillo (FRES) 701.00p -3.58%Randgold Resources Ltd. (RRS) 3,802.00p -2.91%G4S (GFS) 247.90p -2.29%Anglo American (AAL) 1,265.50p -0.94%HSBC Holdings (HSBA) 642.50p -0.89%Glencore Xstrata (GLEN) 305.20p -0.51%Sainsbury (J) (SBRY) 363.50p -0.44%Johnson Matthey (JMAT) 3,205.00p -0.22%BC

Related Shares

More News
Today 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.